12.07.2015 Views

Emerging Viruses-Aids & Ebola - By Leanard ... - preterhuman.net

Emerging Viruses-Aids & Ebola - By Leanard ... - preterhuman.net

Emerging Viruses-Aids & Ebola - By Leanard ... - preterhuman.net

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

[6] Tyrrell OAJ. The common cold research unit: WHOInternational Reference Centre for respiratory virus diseases.WHO Chronicle 1968;22;1:8-11.[7] WHO News and Notes. Ge<strong>net</strong>ic susceptibility to infection.WHO Chronicle 1968;22;4: 162.[8] WHO News and Notes. Studies of the American Indian.WHO Chronicle 1968;22;10:459[9] Barrai I. Human ge<strong>net</strong>ics and public health. WHO Chronicle1970;24;6:246-247.[10] WHO Report. Multipurpose serological surveys. WHOChronicle 1971;25;3:99-101.[11] WHO News and Notes. Large-scale BCG trials. WHOChronicle 1968;22; 11 :496.[12] WHO Current Research Projects. Live measles vaccines.WHO Chronicle 1968;22;12:534-5.[13] WHO Report (Based on a report presented to the TwentyfirstWorld Health Assembly, and on discussions at theAssembly.) The smallpox eradication programme. WHOChronicle 1968;22;8:354-362.[14] WHO Report (Based on a report presented to the TwentysecondWorld Health Assembly.) The smallpox eradicationprogramme. WHO Chronicle 1969;23; 1 0:465-476.[15] WHO News and Notes. Regional Committee for Africa.WHO Chronicle 1969;23;8:341-344.[16] Unfortunately, with the smallpox vaccination as withhepatitis B vaccination, the WHO reported that "in personsvaccinated only in infancy, the incidence of smallpox increaseswith age as immunity diminishes; the data indicate a high degreeof protection for 4-5 years, followed by a slow decline, but evenafter a longer period, smallpox in vaccinated persons is usuallymilder than in unvaccinated persons and this appears to indicatesome residual immunity. Similarly, the difficulty in producing amajor reaction to revaccination lessens with time, but even after10 or 20 years the vaccine required to produce a high percentageof takes must be at least 5-10 times more potent than vaccinesthat will produce the same percentage of takes in primaryvaccinations. The duration of immunity after revaccinationcannot be assessed accurately because not enough is known aboutthe occurrence of smallpox in successfully revaccinated persons.. . ."Quotation from: World Health Organization Report.Communicable diseases in 1970: Some aspects of the WHOprogramme. WHO Chronicle 1971 ;25;6:249-255.[17] Rowe OS. The WHO immunology laboratories at Lausanne.WHO Chronicle 1968;22;11:496.[18] WHO Report (Based on the 1969 report The medicalresearch programme of the World health Organization, 1964-1968, Geneva.) Five years of research of virus diseases. WHOChronicle1969;23;12:564-572.[19] Kalter SS and Heberling. The study of simian viruses. WHO

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!